Seragon Completes Pre-Clinical Study of Aging Intervention Candidate SRN-901
IRVINE, Calif., May 7, 2024 /PRNewswire/ — Seragon Biosciences, Inc. today announced the completion of a pre-clinical study on its novel anti-aging candidate, SRN-901. This...
